Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study).
Turagam MK, Parikh V, Afzal MR, Gopinathannair R, Lavu M, Kanmanthareddy A, Pillarisetti J, Reddy M, Atkins D, Bommana S, Jaeger M, Jeffery C, Mohanty S, Santangeli P, Cheng J, Di Biase L, Narasimhan C, Natale A, Lakkireddy D.
Turagam MK, et al.
J Cardiovasc Electrophysiol. 2017 Aug;28(8):853-861. doi: 10.1111/jce.13254. Epub 2017 Jun 8.
J Cardiovasc Electrophysiol. 2017.
PMID: 28497899
Clinical Trial.